Immediate Impact
2 from Science/Nature 31 standout
Citing Papers
Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis
2025 Standout
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
Works of Gemma Saravanos being referenced
RSV Epidemiology in Australia Before and During COVID-19
2022
COVID-19 public health measures and respiratory syncytial virus
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gemma Saravanos | 336 | 132 | 171 | 18 | 393 | |
| Greta Di Mattia | 260 | 98 | 180 | 26 | 385 | |
| Jojanneke van Summeren | 249 | 74 | 104 | 26 | 347 | |
| Koen Vanden Driessche | 238 | 213 | 102 | 22 | 402 | |
| Kevin T. Shiley | 244 | 123 | 94 | 13 | 375 | |
| Valtýr Thors | 251 | 90 | 88 | 36 | 345 | |
| Miriam Cebey‐López | 237 | 182 | 79 | 25 | 438 | |
| Vasiliki Papaevangelou | 114 | 86 | 69 | 20 | 379 | |
| Mauricio T. Caballero | 263 | 154 | 146 | 23 | 413 | |
| Xiao Li | 262 | 160 | 109 | 23 | 368 | |
| Stephen Aston | 223 | 90 | 77 | 28 | 415 |
All Works
Login with ORCID to disown or claim papers
Loading papers...